PRIMAQUINE AND TAFENOQUINE IN THE PLASMODIUM CYNOMOLGI CAUSAL PROPHYLACTIC MALARIA MODEL

被引：0
|
作者：
DiTusa, Charles A. [1 ]
Gettayacamin, Montip [2 ]
Kozar, Michael P. [1 ]
Lin, Ai J. [1 ]
Fracisco, Susan D. [1 ]
Ohrt, Colin [1 ]
Magill, Alan [1 ]
机构：
[1] Walter Reed Army Inst Res, Silver Spring, MD USA
[2] Armed Forces Res Inst Med Sci, Bangkok 10400, Thailand
来源：
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2010年 / 83卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
270
引用
收藏
页码：81 / 81
页数：1
相关论文
共 50 条
  • [1] Causal Prophylactic Efficacy of Primaquine, Tafenoquine, and Atovaquone-Proguanil Against Plasmodium cynomolgi in a Rhesus Monkey Model
    DiTusa, Charles
    Kozar, Michael P.
    Pybus, Brandon
    Sousa, Jason
    Berman, Jonathan
    Gettayacamin, Montip
    Im-erbsin, Rawiwan
    Tungtaeng, Anchalee
    Ohrt, Colin
    JOURNAL OF PARASITOLOGY, 2014, 100 (05) : 671 - 673
  • [2] Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria
    Llanos-Cuentas, A.
    Lacerda, M. V. G.
    Hien, T. T.
    Velez, I. D.
    Namaik-Iarp, C.
    Chu, C. S.
    Villegas, M. F.
    Val, F.
    Monteiro, W. M.
    Brito, M. A. M.
    Costa, M. R. F.
    Chuquiyauri, R.
    Casapia, M.
    Nguyen, C. H.
    Aruachan, S.
    Papwijitsil, R.
    Nosten, F. H.
    Bancone, G.
    Angus, B.
    Duparc, S.
    Craig, G.
    Rousell, V. M.
    Jones, S. W.
    Hardaker, E.
    Clover, D. D.
    Kendall, L.
    Mohamed, K.
    Koh, G. C. K. W.
    Wilches, V. M.
    Breton, J. J.
    Green, J. A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (03): : 229 - 241
  • [3] Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria
    Quinn, Jane C.
    McCarthy, Stuart
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (19): : 1875 - 1875
  • [4] Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria REPLY
    Green, Justin A.
    Koh, Gavin C. K. W.
    Duparc, Stephan
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (19): : 1876 - 1876
  • [5] Killing of Plasmodium vivax by Primaquine and Tafenoquine
    Markus, Miles B.
    TRENDS IN PARASITOLOGY, 2019, 35 (11) : 857 - 859
  • [6] DIFFERENTIAL SENSITIVITY OF THE PREERYTHROCYTIC STAGES OF PLASMODIUM-CYNOMOLGI-B TO THE PROPHYLACTIC ACTION OF PRIMAQUINE
    PURI, SK
    DUTTA, GP
    TROPICAL MEDICINE AND PARASITOLOGY, 1992, 43 (01): : 70 - 71
  • [7] A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria
    Shanks, GD
    Oloo, AJ
    Aleman, GM
    Ohrt, C
    Klotz, FW
    Braitman, D
    Horton, J
    Brueckner, R
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (12) : 1968 - 1974
  • [8] Extended blood stage sensitivity profiles of Plasmodium cynomolgi to doxycycline and tafenoquine, as a model for Plasmodium vivax
    Christensen, Peter
    Cinzah, Rosy
    Suwanarusk, Rossarin
    Chua, Adeline Chiew Yen
    Kaneko, Osamu
    Kyle, Dennis E.
    Aung, Htin Lin
    Matheson, Jessica
    Bifani, Pablo
    Renia, Laurent
    Cook, Gregory M.
    Snounou, Georges
    Russell, Bruce
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (05)
  • [9] Tafenoquine for the treatment of Plasmodium vivax malaria
    Llanos-Cuentas, Alejandro
    Manrrique, Paulo
    Rosas-Aguirre, Angel
    Herrera, Sonia
    Hsiang, Michelle S.
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (07) : 759 - 768
  • [10] Assessment of the prophylactic activity and pharmacokinetic profile of oral tafenoquine compared to primaquine for inhibition of liver stage malaria infections
    Qigui Li
    Michael O’Neil
    Lisa Xie
    Diana Caridha
    Qiang Zeng
    Jing Zhang
    Brandon Pybus
    Mark Hickman
    Victor Melendez
    Malaria Journal, 13
12345